Enzulu kwiiNtaba ze-Changbai, indalo igcina imfihlelo ekhethekileyo: i-dihydroquercetin. Le nto ikhutshwe kwiingcambu ze-larch yekhulu leminyaka ingaphezulu nje kwento eqhelekileyo yendalo. Sisipho esixabisekileyo esivela kwindalo kuthi, esiqulathe imfihlelo namandla obomi.
Dihydroquercetin,i-bioflavonoid ekhethekileyo, yinkokeli kwintsapho yevithamini kwaye inika uluhlu lweenzuzo ezimangalisayo zempilo.
I. Impembelelo enamandla ye-antioxidant
Dihydroquercetinineempawu ezibalaseleyo ze-antioxidant. Emizimbeni yethu, iimpendulo ze-oxidation zihlala zivelisa iiradicals zasimahla, kwaye iiradicals zasimahla ezigqithisileyo zinokubangela umonakalo kwiiseli kwaye kubangele iingxaki zempilo ezahlukeneyo ezinjengokwaluphala, ukudumba, kunye nezifo zentliziyo. I-Dihydroquercetin inokunciphisa ngokufanelekileyo i-radicals yamahhala kwaye ikhusele iiseli kumonakalo we-oxidative. Umthamo wayo we-antioxidant womelele kune-antioxidants ezininzi eziqhelekileyo ezifana ne-vitamin C kunye ne-vitamin E. Ngokukhupha i-radicals yamahhala, i-dihydroquercetin inceda ukugcina imisebenzi eqhelekileyo yomzimba, ilibazise inkqubo yokuguga, kwaye igcina impilo kunye nokuqina kwesikhumba.
II. Ukukhuselwa kwentliziyo
Kwimpilo ye-cardiovascular, i-dihydroquercetin nayo idlala indima ebalulekileyo. Inokunciphisa i-cholesterol kunye namanqanaba e-triglyceride egazini kunye nokunciphisa umngcipheko we-atherosclerosis. Kwangaxeshanye, i-dihydroquercetin inokwandisa imithambo yegazi, ihlise uxinzelelo lwegazi, kwaye iphucule ukujikeleza kwegazi. Oku kunokubaluleka okulungileyo ekuthinteleni ukwenzeka kunye nophuhliso lwezifo zentliziyo. Ukongeza, kunokunciphisa ukuhlanganiswa kweplatelet kunye nokuba nokwenzeka kwe-thrombosis, ukukhusela ngakumbi inkqubo ye-cardiovascular system.
III. I-Anti-inflammatory effect
Ukuvuvukala kukusabela komzimba kwimixholo eyahlukeneyo, kodwa ukuvuvukala okugqithisileyo kunokubangela umonakalo emzimbeni. I-Dihydroquercetin ineempembelelo ezibalulekileyo ezichasayo. Inokuthintela ukuveliswa kwezinto ezivuthayo kunye nokunciphisa ukuphendula okuvuthayo. Kwezinye izifo ezingapheliyo ezivuthayo ezifana nesifo samathambo kunye ne-enteritis, i-dihydroquercetin inokuba nefuthe elithile le-adjuvant yonyango. Ngokulawula amajoni omzimba, i-dihydroquercetin inceda ukugcina ibhalansi yomzimba kwaye inciphisa umonakalo wokudumba emzimbeni.
IV. Impembelelo ye-Anti-tumor
Kwiminyaka yakutshanje, uphononongo lufumene ukuba i-dihydroquercetin nayo inamandla athile e-antitumor. Inokuthintela ukukhula kunye nokwanda kweeseli zethumba kwaye yenze i-apoptosis yeseli yethumba. Kwangaxeshanye, i-dihydroquercetin inokwandisa ukhuseleko lomzimba kunye nokuphucula amandla e-antitumor. Nangona uphando malunga nesiphumo se-antitumor ye-dihydroquercetin lusekwinqanaba lokuqala, oku kufunyanisiweyo kubonelela ngeembono ezintsha kunye nezalathiso kunyango lwamathumba.
Ngenxa ye-antioxidant kunye ne-anti-inflammatory effects ye-dihydroquercetin, isetyenziswe ngokubanzi kwintsimi yezithambiso. Kwiimveliso zokhathalelo lwesikhumba, i-dihydroquercetin inokunceda ukuxhathisa umonakalo weeradicals zasimahla kunye nokunciphisa imiqondiso yokuguga kwesikhumba njengemibimbi kunye nokuwohloka. Inokunciphisa ukudumba kwesikhumba kunye nokuphucula ulusu olubuthathaka. Ukongeza i-dihydroquercetin kwizinto zokuthambisa ayinakuphucula kuphela ukusebenza kweemveliso kodwa ikwakhawulelana neemfuno zabathengi zezithambiso zendalo nezikhuselekileyo.
Ukuququmbela,dihydroquercetin, isicatshulwa se-larch, sinemisebenzi emininzi ebalulekileyo. I-antioxidant yayo, ukhuseleko lwe-cardiovascular, anti-inflammatory, antitumor kunye nezinye iziphumo ziye zazisa izibonelelo ezininzi kwimpilo yethu. Ngokuqhubeka kokwenziwa nzulu kophando lwenzululwazi, kukholelwa ukuba imisebenzi emininzi ye-dihydroquercetin iya kufunyanwa, inegalelo elikhulu ekuphuculeni impilo yabantu kunye nomgangatho wobomi.
Iinkcukacha zoqhakamshelwano:
XI'AN BIOF BIO-TECHNOLOGY CO.,LTD
Email: Winnie@xabiof.com
Umnxeba/WhatsApp: +86-13488323315
Iwebhusayithi:https://www.biofingredients.com
Ixesha lokuposa: Sep-05-2024
